Search - tctmd.com

Displaying 21 - 40 of 169

Sort: Relevancy | Date

Presentation TCT 2025

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

Presenter: Kornel Kakonyi

October 26, 2025

Presentation TCT 2025

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

Presenter: Rafal Adam Januszek

October 26, 2025

Presentation TCT 2025

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

Presenter: Christina Lalani

October 26, 2025

Presentation TCT 2025

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

Presenter: Neal S. Kleiman

October 26, 2025

Presentation TCT 2025

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

Presenter: Aditya Mantha

October 26, 2025

Presentation TCT 2025

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

Presenter: Prakriti Gaba

October 26, 2025

Presentation TCT 2025

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

Presenter: Jennifer Rymer

October 26, 2025

Presentation TCT 2025

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

Presenter: Haseeb Ur Rahman

October 26, 2025

Presentation TCT 2025

TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis

Presenter: Chloe Kharsa

October 26, 2025

Presentation TCT 2025

TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis

Presenter: Mangesh Kritya

October 26, 2025

Presentation TCT 2025

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

Presenter: Ankit Hanmandlu

October 26, 2025

Presentation TCT 2025

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

Presenter: Jasvindar Singh

October 26, 2025

Presentation TCT 2025

TCT 1708: Kissing DCBs in NSTEMI: Sirolimus-Coated Balloon Use With Selution™ for ISR and Stent Thrombosis in a Bifurcation Lesion

Presenter: Davit Baghdasaryan

October 26, 2025

Presentation TCT India 2025

Deep dive on Stent Failure / ISR: Cut – DEB strategy!

Presenter: Y. Vijayachandra Reddy

July 25, 2025

Presentation TCT India 2025

Contrast-enhanced laser for ISR – neo-intimal hyperplasia versus stent under-expansion

Presenter: Rajendra Kumar Jain

July 25, 2025

Presentation Fellows 2025

MODERN PCI to Achieve Optimal DCB Treatment (including a case study)

Presenter: Margaret B. McEntegart

May 16, 2025

Presentation Fellows 2025

AVVIGO+ Innovation in Stent Failure Imaging

Presenter: Megha Prasad

May 16, 2025

Presentation Fellows 2025

ISR: Why the Why Matters

Presenter: Ajay J. Kirtane

May 16, 2025

Presentation TCT 2024

From ISR to De Novo Lesions: Keys to Success in Patient Selection for PCI With DCBs

Presenter: Sandeep Basavarajaiah

October 30, 2024

Presentation TCT 2024

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

Presenter: Robert Yeh

October 29, 2024

Advertisement

TCT 189: Follow-up of Flow-Reserve-Guided Treatment for In-Stent Restenosis of Drug-Eluting Coronary Stents

TCT 179: In-Stent Restenosis in Chronic Kidney Failure: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents

TCT 178: Use of the AGENT Paclitaxel-Coated Balloon in the United States Shortly After FDA Approval: Early Results from the AGENT Post-Approval Study

TCT 180: Paclitaxel-Coated Balloon versus Uncoated Balloon for Coronary In-Stent Restenosis in Patients with Acute Coronary Syndromes: A Subanalysis of the AGENT IDE Trial

TCT 182: Impact of Lesion Preparation Strategy on the Efficacy of Paclitaxel Coated Balloon for Coronary In-stent Restenosis: A Subgroup Analysis of the AGENT IDE Randomized Trial

TCT 181: Efficacy and Safety of Coronary Angioplasty Using a Paclitaxel-Coated vs Uncoated Balloon in Patients with In-Stent Restenosis Stratified by Restenosis Risk: A Subanalysis of the AGENT IDE

TCT 175: Contemporary Trends for the Treatment of In-Stent Restenosis in the United States: Insights from the CathPCI Registry

TCT 174: A Comparative Analysis of Clinical Outcomes in Patients with In-Stent Restenosis Undergoing Percutaneous Coronary Intervention with Drug Coated Balloons and Drug Eluting Stents

TCT 172: Outcomes of Radiation Overlap and Margin Length in Intracoronary Brachytherapy for In-Stent Restenosis

TCT 173: Sex-Based Differences in Long-Term Outcomes Following Intravascular Brachytherapy for In-Stent Restenosis

TCT 176: Mid-Term Outcomes of PCI in In-Stent Restenosis versus De-Novo Lesions in an Urban Center with a Large African American Population: An Updated Retrospective Analysis

TCT 177: Procedural Success of Excimer Laser Coronary Angioplasty in the Setting of In-stent Restenosis: Meta Analyses

TCT 1708: Kissing DCBs in NSTEMI: Sirolimus-Coated Balloon Use With Selution™ for ISR and Stent Thrombosis in a Bifurcation Lesion

Deep dive on Stent Failure / ISR: Cut – DEB strategy!

Contrast-enhanced laser for ISR – neo-intimal hyperplasia versus stent under-expansion

MODERN PCI to Achieve Optimal DCB Treatment (including a case study)

AVVIGO+ Innovation in Stent Failure Imaging

ISR: Why the Why Matters

From ISR to De Novo Lesions: Keys to Success in Patient Selection for PCI With DCBs

Balancing Clinical Outcomes with Utilization in Clinical Practice - Case Example = The Agent ISR DCB

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content